First clinical trial of innovative cancer drug targeting HSF1 pathway begins

The first cancer patients are to receive doses of an innovative new drug that targets a master regulatory pathway in cells, as part of a new clinical trial.

source https://medicalxpress.com/news/2022-01-clinical-trial-cancer-drug-hsf1.html